PTEN and prostate carcinoma: PTEN expression and function is regulated by various mechanisms, including regulation by miRNAs65, and its co-inactivation has been reported to increase the neuroendocrine phenotype, a hallmark of prostate cancer progression during anti-androgen therapy66.